Miruto Tanaka
Overview
Explore the profile of Miruto Tanaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanaka M, Yasuda H, Nakamura S, Shimazawa M
Invest Ophthalmol Vis Sci
. 2024 Jul;
65(8):16.
PMID: 38980271
Purpose: The cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) stimulator of interferon gene (STING) pathway is a crucial cascade in the inflammatory response initiated by the recognition of cytosolic double-stranded DNA...
2.
Tanaka M, Nakamura S, Sakaue T, Yamamoto T, Maekawa M, Nishinaka A, et al.
Arterioscler Thromb Vasc Biol
. 2023 Apr;
43(6):927-942.
PMID: 37078291
Background: Endothelial cell activation is tightly controlled by the balance between VEGF (vascular endothelial cell growth factor) and Notch signaling pathway. VEGF destabilizes blood vessels and promotes neovascularization, which are...
3.
Nishinaka A, Tanaka M, Ohara K, Sugaru E, Shishido Y, Sugiura A, et al.
Exp Eye Res
. 2023 Feb;
228:109405.
PMID: 36773739
This study aimed to determine the role of transient receptor potential vanilloid 4 (TRPV4), a calcium (Ca)-permeable cation channel, in the pathophysiology of retinal vascular disease. The retinal vein occlusion...
4.
Nishinaka A, Tanaka M, Aoshima K, Kuriyama A, Sasaki T, Otsu W, et al.
FASEB J
. 2022 Apr;
36(6):e22323.
PMID: 35485981
Neovascular glaucoma (NVG) is caused by the formation of new blood vessels in the angle, iris, and cornea in retinal ischemic disease, such as proliferative diabetic retinopathy (PDR) and retinal...
5.
Yasuda H, Tanaka M, Nishinaka A, Nakamura S, Shimazawa M, Hara H
Int J Mol Sci
. 2021 Aug;
22(16).
PMID: 34445595
Neovascular age-related macular degeneration (nAMD) featuring choroidal neovascularization (CNV) is the principal cause of irreversible blindness in elderly people in the world. Integrated stress response (ISR) is one of the...
6.
Ishida K, Yako T, Tanaka M, Otsu W, Nakamura S, Shimazawa M, et al.
Biol Pharm Bull
. 2021 Jul;
44(7):937-946.
PMID: 34193689
The corneal epithelium is continuously exposed to oxygen, light, and environmental substances. Excessive exposure to those stresses is thought to be a risk factor for eye diseases. Photokeratitis is damage...
7.
Tanaka M, Inoue Y, Imai T, Tanida N, Takahashi K, Hara H
Curr Neurovasc Res
. 2021 May;
18(1):85-92.
PMID: 34011258
Background: Neovascular age-related macular degeneration (AMD) with choroidal neovascularization (CNV) is a leading cause of blindness in elderly people. Anti-vascular endothelial growth factor (anti-VEGF)-drugs are used to treat AMD patients;...
8.
Yamamoto T, Nitta K, Nishinaka A, Tanaka M, Nakamura S, Shimazawa M, et al.
Exp Eye Res
. 2021 Jan;
204:108453.
PMID: 33503450
Retinal vein occlusion (RVO) is an intractable eye disease that results in reduced visual acuity, associated with retinal ischemia, hemorrhage, and edema. RVO results in excessive ROS production in the...
9.
Nishinaka A, Nakamura S, Tanaka M, Masuda T, Inoue Y, Yamamoto T, et al.
FASEB J
. 2021 Jan;
35(2):e21313.
PMID: 33484194
Anti-vascular endothelial growth factor (VEGF) therapies are now the first-line treatment for many ocular diseases, but some patients are non-responders to these therapies. The purpose of this study was to...
10.
Ando S, Tanaka M, Chinen N, Nakamura S, Shimazawa M, Hara H
In Vivo
. 2020 Nov;
34(6):3247-3254.
PMID: 33144430
Background/aim: In spinal muscular atrophy (SMA), systemic deficiency of survival motor neurons (SMN) caused by loss or mutation of SMN1 leads to SMA symptoms. SMA was, for a long time,...